This free IWMF- CancerCare workshop for WM Caregivers features Dr. Jeffrey Matous (Colorado Blood Cancer Institute) and Ms. Sharon Flynn (National Institutes of Health).
With an emphasis on WM, the IWMF 2019 Venetoclax Fact Sheet explains how the therapy is given, side effects, and self-care tips.
Jeannette Quiroz underwent pregnancy testing while being tested for WM at the age of 35. To her surprise, both were confirmed.
View Jeanette's Story of Hope HERE
The IWMF has positioned itself to enhance the support provided to the global WM community and to search for a cure with the addition of a new Chief Development Officer.
Availability of a free air transportation service for individuals requiring medical diagnosis, treatment or follow-up.
Michael was the first Australian to have ibrutinib treatment and it’s been lifesaving. “My life is normal now,” said Michael, 69, of Milton in regional New South Wales.
IVIG Fact Sheet and WhiMSICAL Patient Registry are proving to be valuable sources of IVIG information to the WM patient/caregiver community and to the healthcare community.
With an emphasis on WM, the IWMF 2019 Human Intravenous Immunoglobulin Therapy (IVIG) Fact Sheet explains how the therapy is given, side effects, and self-care tips.
Preliminary results of WM patients in the LLS Patient Registry are now available. The IWMF and CLL Society were the first two lymphoma organizations invited to participate.
An exciting leadership change is taking place to enable the IWMF to better serve our members, affiliates and partners, and to enhance our search for a cure!